MDS
Briqulimab Phase I Study Doses First Patient With Lower-Risk MDS
SG Tylor
Source – Jasper Therapeutics Jasper Therapeutics has initiated a Phase I trial (NCT05903274) to evaluate the use of briquilimab as ...
Source – Jasper Therapeutics Jasper Therapeutics has initiated a Phase I trial (NCT05903274) to evaluate the use of briquilimab as ...